Oneness Biotech Co., Ltd.

ON101

Journal Publication	Date	Type	Title
Life Sciences	10 Jun. 2025	Publication	ON101 counteracts oxidative stress and inflammation in radiation-induced dermatitis through Keap1/Nrf2 signaling
Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics	21 May 2025	Publication	Cost-effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi-ethnic country in Asia
The Journal of Food and Drug Analysis	27 Mar. 2025	Publication	Within-trial cost-effectiveness of novel macrophage-regulating treatment on wound healing in patients with diabetic foot ulcers
Mary Ann Liebert	5 Sep. 2024	Publication	Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc Analysis
Chinese Journal of Endocrinology and Metabolism	25 July 2024	Publication	Expert consensus on wound treatment of diabetic foot ulcer(2024)
The Journal of Taiwan Society of Plastic Surgery	19 June 2024	Publication	Efficacy of ON101 cream, a Topical Macrophage-Regulating Cream, against Chronic Burn Wounds—A Case Report and Literature Review
Case Reports in Clinical Medicine	28 May 2024	Publication	ON101 Cream Increases the Wound Healing Rate in Diabetic Patients with Uremia—Cases Report
JAMA Network Open	13 Jan. 2023	Publication	Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
Aesthetic Surgery Journal	10 Jan. 2023	Publication	Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis
Annals of Case Reports	28 Dec. 2022	Publication	Macrophage-Regulating Drug Treatment Promotes Tissue Proliferation in a Diabetic Foot Ulcer Patient with Exposed Anterior Tibialis Tendon - A Case Report
Pharmaceutics	27 Sep. 2022	Publication	New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers
JID Innovations	1 Jun. 2022	Publication	Restoring Pro-healing/remodeling- associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing
JAMA Network Open	3 Sep. 2021	Publication	Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers
Frontiers in Pharmacology	28 May 2019	Publication	Extract From Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1β Through Inhibition of NF-κB Nuclear Translocation and NLRP3 Inflammasome Activation
Evidence-based complementary and alternative medicine	30 May 2012	Publication	Plectranthus Amboinicus and Centella Asiatica Cream for the Treatment of Diabetic Foot Ulcers
Conference Publication	Date	Type	Title
EWMA 2025	26 Mar. 2025	Poster Presentation	CASE SERIES OF COMPLETE HEALING WITH MACROPHAGE-REGULATING DRUG ON101 CREAM ON TREATMENT ON WAGNER GRADE 2 TO 3 DIABETIC FOOT ULCER
EWMA 2025	26 Mar. 2025	Poster Presentation	REAL-WORLD EFFECTIVENESS AND DOSE RESPONSE OF ON101 THERAPY FOR HEALING OF DIABETIC FOOT ULCERS
TSBIWH Annual Meeting 2024	7 Sep. 2024	Oral Presentation	Enhanced Diabetic Foot Ulcer Healing with ON101 and Artificial Dermis: A Case Study
SAWC Spring 2024	14 May 2024	Poster Presentation	Optimizing Wound Bed and Diabetic Foot Ulcer Healing with Proprietary Natural Herbal Cream - A Case Series in the US
SAWC Spring 2024	14 May 2024	Poster Presentation	The Clinical Practice of a Proprietary Natural Herbal Cream in Limb Salvage of a Patient with Multiple Co-morbidities: A Case Report
EADV Congress 2023	11 October 2023	Poster Presentation	Protection Effect of Macrophage-Regulation Drug for Acute Radiation Dermatitis (ARD):From Preclinical Pharmacology to Real-World Proof-of-Concept Study
EASD Annual Meeting 2023	3 Oct. 2023	Oral Presentation	Effect of macrophage-regulating new drug in treatment of diabetic foot ulcers- From phase 3 MRCT to real-world
ADA Annual Meeting 2023	24 Jun. 2023	Oral Presentation	100-OR A novel macrophage-regulation new drug in treating diabetic foot ulcer-a phase III MRCT study and Taiwan experience.
ISPOR 2023	10 May 2023	Poster Presentation	Economic Value of a Novel Macrophage-Regulating Treatment for Diabetic Foot Ulcers from a Healthcare Sector Perspective
ISPOR 2023	10 May 2023	Poster Presentation	(Abstract)
ISDF 2023	10 May 2023	Poster Presentation	324-Wound Healing Risk Factors - A Phase 3 RCT Post-hoc Analysis of a Novel Macrophage-regulating Drug.
			323-The Value of a Novel Macrophage-Regulating Drug for Diabetic Foot Ulcers: A Cost-Effectiveness Analysis
			321-Effect of a Macrophage-regulating New Drug in Treatment of Diabetic Foot Ulcers: from Phase 3 RCT to Real-world RCT Post-hoc Analysis of a Novel Macrophage-regulating Drug.
EWMA 2023	5 May 2023	Oral Presentation	A novel macrophage-regulating drug promotes diabetic foot ulcers healing - Phase 3 MRCT study and post-hoc analysis
			A Macrophage-regulating Cream on Wound Healing in Patients with Diabetic Foot Ulcers
			(View Abstract: Page 441)
2023 Annual Meeting of TSA	18 Mar. 2023	Poster Presentation	The effect of topical treatment with Fespixon cream on chronic burn wound: A case report and literature review
2023 Annual Meeting of TSWC	11 Mar. 2023	Oral Presentation	Effect of a Novel Macrophage-Regulating Drug on complicated Diabetic Foot Ulcers: Case reports
2023 Annual Meeting of TSWC	11 Mar. 2023	Oral Presentation	(View Abstract: Page 35)
IDF Diabetes Atlas 2022	7 Dec. 2022	Oral Presentation	LI2022-0284 Risk Factor Influencing Complete Healing in DFU Patients - Post-Hoc Analysis of a Phase 3 MRCT of Macrophage-Regulation New Drug
CDS 2022	4 Dec. 2022	Oral Presentation	Macrophage-regulation drug(ON101) In treating difficult Diabetic Foot Ulcer
ESDR 51st Annual Meeting	28 Sep. 2022	Poster Presentation	Macrophage-regulating Drug Healed a Diabetic foot Ulcer with Gangrene and Osteomyelitis
ADA Annual Meeting 2022	1 Jun. 2022	Poster Presentation	490-P: Macrophage-Regulating Drug Promotes Tissue Proliferation in a DFU Real-World Case
IDF 2021	1 Apr. 2022	Oral Presentation	IDF21-0431 A Novel Formulation that Regulates Subsets of Macrophages Accelerates Diabetic Ulcer Healing
WUWHS 2022	2 Mar. 2022	Oral Presentation	A New Drug Promotes Wound Healing in Treatment of Chronic Diabetic Foot Ulcers by Regulating Macrophages
WUWHS 2022	2 Mar. 2022	Oral Presentation	(View Abstract: Page 5)
EASD Annual Meeting 2021	30 Sep. 2022	Oral Presentation	A M1/M2-Macrophages-Regulating New Drug for Diabetic Foot Ulcers with Poor-Controlled HbA1c Risk Factor in an International Phase 3 Study
EASD Annual Meeting 2021	30 Sep. 2022	Oral Presentation	(View Abstract: 196)
EWMA 2020	18 Nov. 2020	Oral Presentation	A Novel Topic Drug Proved Superior Efficacy from Global Ph3 on Diabetic Foot Ulcer

FB825

Presentation / Publication	Date	Type	Title
Pediatric Allergy and Immunology	19 Apr. 2016	Publication	Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody
The Journal of Immunology	1 May 2015	Publication	Developing an antibody targeting CϵmX of mIgE for the treatment of IgE-mediated diseases (HYP4P.305)
The Journal of Immunology	1 May 2014	Publication	Developing an antibody targeting CϵmX of mIgE for the treatment of allergic and other IgE-mediated diseases (VAC6P.954)
Nature Communications	24 Jan. 2014	Publication	Two potential therapeutic antibodies bind to a peptide segment of membrane-bound IgE in different conformations
Molecular Immunology	Volume 52, Issues 3–4 Oct.–Dec. 2012	Publication	CɛmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes
Immunogenetics	24 Mar. 2010	Publication	Genetic variations in the CεmX domain of human membrane-bound IgE
The Journal of Immunology	15 Feb. 2010	Publication	Unique Epitopes on CεmX in IgE–B Cell Receptors Are Potentially Applicable for Targeting IgE-Committed B Cells
The Journal of Immunology	1 Apr. 2009	Publication	Humanization of an anti-CεmX monoclonal antibody 4B12 for potential clinical use in targeting mIgE+B cells (140.19)

SNS812

Presentation / Publication	Date	Type	Title
The American Thoracic Society	20 May 2025	Oral Presentation	SNS812, a Broad-Spectrum Antiviral siRNA, Demonstrates Safty and Clinical Efficacy in Treating COVID-19 in Phase I & II Trial
Clinical and Translational Science	21 Mar. 2025	Publication	Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects
EMBO Molecular Medicine	21 Feb. 2022	Publication	A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant
EMBO Molecular Medicine	21 Feb. 2022	Publication	Commentary: RNAi to treat SARS-CoV-2—variant proofing the next generation of therapies

OB318

Presentation / Publication	Date	Type	Title
Cancers	26 Oct. 2019	Publication	Novel Antrodia cinnamomea Extract Reduced Cancer Stem-Like Phenotype Changes and Resensitized KRAS-Mutant Colorectal Cancer via a MicroRNA-27a Pathway
Journal of Agricultural and Food Chemistry	10 Dec. 2014	Publication	4-Acetylantroquinonol B Suppresses Tumor Growth and Metastasis of Hepatoma Cells via Blockade of Translation-Dependent Signaling Pathway and VEGF Production

Presentation / Publication

Date

Type

Title